IDSA/SHEA 2021成人艰难梭菌感染管理重点更新指南
该指南由美国感染病学会(IDSA)与美国医疗流行病学会(SHEA)多学科专家组制定,是对成人艰难梭菌感染(CDI)管理的重点更新,专门针对非达霉素与贝洛托珠单抗的治疗使用。推荐基于主题特异性系统文献综述,并按GRADE方法评定证据确定性等级与推荐强度。
要点
- 本指南聚焦非达霉素与贝洛托珠单抗在成人CDI治疗中的应用。
- 由IDSA与SHEA多学科专家组制定,面向感染科等照护成人CDI的医务人员。
- 推荐意见基于系统文献综述,采用GRADE方法评定证据与推荐强度。
核心结论
- 该重点更新指南针对成人艰难梭菌感染管理中非达霉素与贝洛托珠单抗的使用给出推荐。
研究设计与样本
- 由代表IDSA与SHEA的多学科专家组制定,推荐基于主题特异性系统文献综述,采用GRADE方法评定证据确定性与推荐强度。
临床怎么用
- 适用于照护成人CDI患者的感染病专科、消化科、住院医师、药师等医务人员参考使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI. This guideline was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). This guideline is intended for use by healthcare professionals who care for adults with CDI, including specialists in infectious diseases, gastroenterologists, hospitalists, pharmacists, and any clinicians and healthcare providers caring for these patients. The panel's recommendations for the management CDI are based upon evidence derived from topic-specific systematic literature reviews. Summarized below are the recommendations for the management of CDI in adults. The panel followed a systematic process which included a standardized methodology for rating the certainty of the evidence and strength of recommendation using the GRADE approach (Grading of Recommendations Assessment, Development, and Evaluation). A detailed description of background, methods, evidence summary and rationale that support each recommendation, and knowledge gaps can be found online in the full text.
引用
- Johnson S, Lavergne V, Skinner AM, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021. PMID: 34492699. doi:10.1093/cid/ciab718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。